Skip to main content

Advertisement

SpringerLink
Log in

Triiodothyronine (T3) and 1,25-dihydroxyvitamin D3 (1,25D3) Inversely Regulate OPG Gene Expression in Dependence of the Osteoblastic Phenotype

  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Abstract

Both thyroid hormones and 1,25-dihydroxyvitamin D3 (1,25D3) are essential for normal development and maintenance of the skeleton. They regulate osteoblastic differentiation by influencing expression of osteoblast specific genes like osteocalcin (OCN). Mice deficient in OCN, the most abundant noncollagenous protein of the bone matrix, develop a phenotype characterized by higher bone mass and bone of improved quality. Osteoprotegerin (OPG), another protein important for bone metabolism, protects bone and is a regulator of the osteoclast development. 1,25D3 down regulates the basal expression of these two proteins in osteoblasts and osteoblast-like cells. The involvement of these hormones and proteins in the bone metabolism guided us to compare their regulation in cell lines with different osteoblastic phenotypes. We found that T3 increased OCN mRNA levels in MC3T3-E1 osteoblastic cells independent from their phenotype albeit with different potency but not in the bone marrow-derived stromal cell line ST2. OPG mRNA expression levels were only stimulated by T3 in mature MC3T3-E1 cells, which have the capacity to mineralize, but not in pre-osteoblastic MC3T3-E1 cells or in ST2 cells. In the mineralizing osteoblastic cells 1,25D3 inhibited T3-induced expression for OPG mRNA but not OCN mRNA. In the pre-osteoblastic cell line with undetectable OPG mRNA levels, either basal or T3-stimulated, 1,25D3 inhibited OCN mRNA expression completely. Our results emphasize the importance of balanced regulation of mRNA transcript levels for OPG and OCN, by both hormones and probably other systemic factors to enable a fine-tuning of bone metabolism at specific skeletal sites.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. WS Simonet DL Lacey CR Dunstan et al. (1997) ArticleTitleOsteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89 309–319 Occurrence Handle9108485

    PubMed  Google Scholar 

  2. E Tsuda M Goto S Mochizuki K Yano F Kobayashi T Morinaga K Higashio (1997) ArticleTitleIsolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochem Biophys Res Commun 234 137–142 Occurrence Handle10.1006/bbrc.1997.6603 Occurrence Handle1:CAS:528:DyaK2sXjt1ynsLw%3D Occurrence Handle9168977

    Article  CAS  PubMed  Google Scholar 

  3. H Yasuda N Shima N Nakagawa et al. (1998) ArticleTitleIdentity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 139 1329–1337 Occurrence Handle9492069

    PubMed  Google Scholar 

  4. T Suda N Takahashi N Udagawa E Jimi MT Gillespie TJ Martin (1999) ArticleTitleModulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 20 345–357 Occurrence Handle10368775

    PubMed  Google Scholar 

  5. JE Aubin E Bonnelye (2000) ArticleTitleOsteoprotegerin and its ligand; a new paradigm for regulation of osteoclastogenesis and bone resorption. Medscape Womens Health 5 5 Occurrence Handle1:STN:280:DC%2BD3c3ltlGkug%3D%3D

    CAS  Google Scholar 

  6. S Khosla (2001) ArticleTitleMinireview: the OPG/RANKL/RANK system. Endocrinology 142 5050–5055 Occurrence Handle1:CAS:528:DC%2BD3MXovVSntb8%3D Occurrence Handle11713196

    CAS  PubMed  Google Scholar 

  7. P Ducy C Desbois B Boyce et al. (1996) ArticleTitleIncreased bone formation in osteocalcin-deficient mice. Nature 382 448–452 Occurrence Handle1:CAS:528:DyaK28Xks1Olur0%3D Occurrence Handle8684484

    CAS  PubMed  Google Scholar 

  8. TJ Allain AM McGregor (1993) ArticleTitleThyroid hormones and bone. J Endocrinol 139 9–18 Occurrence Handle1:CAS:528:DyaK2cXitlKrsA%3D%3D Occurrence Handle8254298

    CAS  PubMed  Google Scholar 

  9. L Mosekilde EF Eriksen P Charles (1990) ArticleTitleEffects of thyroid hormones on bone and mineral metabolism. Endocrinol Metab Clin North Am 19 35–63

    Google Scholar 

  10. R Kitazawa S Kitazawa S Maeda (1999) ArticleTitlePromoter structure of mouse RANKL/TRANCE/OPGL/ODF gene. Biochim Biophys Acta 1445 134–141 Occurrence Handle1:CAS:528:DyaK1MXis1alurY%3D Occurrence Handle10209265

    CAS  PubMed  Google Scholar 

  11. M Nagai N Sato (1999) ArticleTitleReciprocal gene expression of osteoclastogenesis inhibitory factor and osteoclast differentiation factor regulates osteoclast formation. Biochem Biophys Res Commun 257 719–723 Occurrence Handle10.1006/bbrc.1999.0524 Occurrence Handle1:CAS:528:DyaK1MXisVaiurk%3D Occurrence Handle10208850

    Article  CAS  PubMed  Google Scholar 

  12. GP Thomas SU Baker JA Eisman EM Gardiner (2001) ArticleTitleChanging RANKL/OPG mRNA expression in differentiating murine primary osteoblasts. J Endocrinol 170 451–460 Occurrence Handle1:CAS:528:DC%2BD3MXmt1Skt7Y%3D Occurrence Handle11479141

    CAS  PubMed  Google Scholar 

  13. F Gori LC Hofbauer CR Dunstan TC Spelsberg S Khosla BL Riggs (2000) ArticleTitleThe expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromal-osteoblast lineage cells is developmentally regulated. Endocrinology 141 4768–4776 Occurrence Handle1:CAS:528:DC%2BD3cXosVSqt7o%3D Occurrence Handle11108292

    CAS  PubMed  Google Scholar 

  14. F Varga M Rumpler E Luegmayr N Fratzl-Zeeman H Glantschnig K Klaushofer (1997) ArticleTitleTriiodothyronine, a regulator of osteoblastic differentiation: depression of histone H4, attenuation of c-fos/c-jun, and induction of osteocalcin expression. Calcif Tissue Int 61 404–411 Occurrence Handle10.1007/s002239900356 Occurrence Handle1:CAS:528:DyaK2sXntlCisro%3D Occurrence Handle9351883

    Article  CAS  PubMed  Google Scholar 

  15. N Fratzl-Zelman P Fratzl H Hörandner B Grabner F Varga A Ellinger K Klaushofer (1998) ArticleTitleMatrix mineralization in MC3T3-E1 cell cultures initiated by beta-glycerophosphate pulse. Bone 23 511–520 Occurrence Handle10.1016/S8756-3282(98)00139-2 Occurrence Handle1:CAS:528:DyaK1MXlslCm Occurrence Handle9855459

    Article  CAS  PubMed  Google Scholar 

  16. D Wang K Christensen K Chawla G Xiao PH Krebsbach RT Franceschi (1999) ArticleTitleIsolation and characterization of MC3T3-E1 preosteoblast subclones with distinct in vitro and in vivo differentiation/mineralization potential. J Bone Miner Res 14 893–903 Occurrence Handle1:CAS:528:DyaK1MXjvFKqtb0%3D Occurrence Handle10352097

    CAS  PubMed  Google Scholar 

  17. F Varga S Spitzer M Rumpler K Klaushofer (2003) ArticleTitle1,25-dihydroxyvitamin D3 inhibits thyroid hormone-induced osteocalcin expression in mouse osteoblast-like cells via a thyroid hormone response element. J Mol Endocrinol 30 49–57 Occurrence Handle1:CAS:528:DC%2BD3sXitFWnu7o%3D Occurrence Handle12580760

    CAS  PubMed  Google Scholar 

  18. E Otsuka A Yamaguchi S Hirose H Hagiwara (1999) ArticleTitleCharacterization of osteoblastic differentiation of stromal cell line ST2 that is induced by ascorbic acid. Am J Physiol . C132–C138

    Google Scholar 

  19. M Wilkinson (1988) ArticleTitleRNA isolation: a mini-prep method. Nucl Acid Res 16 10933 Occurrence Handle1:CAS:528:DyaL1MXjs1Cntg%3D%3D

    CAS  Google Scholar 

  20. AJ Celeste V Rosen JL Buecker R Kriz EA Wang JM Wozney (1986) ArticleTitleIsolation of the human gene for bone gla protein utilizing mouse and rat cDNA clones. Embo J 5 1885–1890 Occurrence Handle1:CAS:528:DyaL28XlvVGjtro%3D Occurrence Handle3019668

    CAS  PubMed  Google Scholar 

  21. JL Frendo G Xiao S Fuchs RT Franceschi G Karsenty P Ducy (1998) ArticleTitleFunctional hierarchy between two OSE2 elements in the control of osteocalcin gene expression in vivo. J Biol Chem 273 30509–30516 Occurrence Handle10.1074/jbc.273.46.30509 Occurrence Handle1:CAS:528:DyaK1cXnsVyru7g%3D Occurrence Handle9804819

    Article  CAS  PubMed  Google Scholar 

  22. K Thirunavukkarasu DL Halladay RR Miles X Yang RJ Galvin S Chandrasekhar TJ Martin JE Onyia (2000) ArticleTitleThe osteoblast-specific transcription factor Cbfa1 contributes to the expression of osteoprotegerin, a potent inhibitor of osteoclast differentiation and function. J Biol Chem 275 25163–25172 Occurrence Handle1:CAS:528:DC%2BD3cXmtVeiuro%3D Occurrence Handle10833509

    CAS  PubMed  Google Scholar 

  23. M Schräder KM Muller C Carlberg (1994) ArticleTitleSpecificity and flexibility of vitamin D signaling. Modulation of the activation of natural vitamin D response elements by thyroid hormone. J Biol Chem 269 5501–5504 Occurrence Handle8119880

    PubMed  Google Scholar 

  24. M Raval-Pandya LP Freedman H Li S Christakos (1998) ArticleTitleThyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation. Mol Endocrinol 12 1367–1379 Occurrence Handle1:CAS:528:DyaK1cXmtVyjtbw%3D Occurrence Handle9731705

    CAS  PubMed  Google Scholar 

  25. R Zhang P Ducy G Karsenty (1997) ArticleTitle1,25-dihydroxyvitamin D3 inhibits osteocalcin expression in mouse through an indirect mechanism. J Biol Chem 272 110–116 Occurrence Handle10.1074/jbc.272.1.110 Occurrence Handle1:CAS:528:DyaK2sXjsVGgtQ%3D%3D Occurrence Handle8995235

    Article  CAS  PubMed  Google Scholar 

  26. K Klaushofer O Hoffmann E Czerwenka U Konig K Koller M Peterlik (1989) ArticleTitleInterferon gamma and calcitonin induce differential changes in cellular kinetics and morphology of osteoclasts in cultured neonatal mouse calvaria. J Bone Miner Res 4 585–606

    Google Scholar 

  27. T Ikeda M Utsuyama K Hirokawa (2001) ArticleTitleExpression profiles of receptor activator of nuclear factor kappaB ligand, receptor activator of nuclear factor kappaB, and osteoprotegerin messenger RNA in aged and ovariectomized rat bones. J Bone Miner Res 16 1416–1425

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Ludwig Boltzmann Institute of Osteology, 4th Medical Department, Hanusch Hospital A-1140 Vienna, Austria

    F. Varga, S. Spitzer & K. Klaushofer

Authors
  1. F. Varga
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Spitzer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. Klaushofer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to K. Klaushofer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Varga, F., Spitzer, S. & Klaushofer, K. Triiodothyronine (T3) and 1,25-dihydroxyvitamin D3 (1,25D3) Inversely Regulate OPG Gene Expression in Dependence of the Osteoblastic Phenotype . Calcif Tissue Int 74, 382–387 (2004). https://doi.org/10.1007/s00223-003-0033-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00223-003-0033-5

Keywords

Search

Navigation